PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms

Gynecological Endocrinology

Volumn 28, Issue 5, 2012, Pages 375-377

  Mohiyiddeen, Lamiya ^a   Salim, Serena ^a   Mulugeta, Betselot ^a   McBurney, Helen ^b   Newman, William G ^b   Pemberton, Phil ^c   Nardo, Luciano G ^b,d  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d Reproductive Medicine and Surgery Unit   (United Kingdom)

Author keywords

Anti mullerian hormone; FSH receptor; Ovulation induction; PCOS; Ser680Asn; Single nucleotide polymorphism

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROGESTERONE;

ADULT; ANOVULATION; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; ANTI-MULLERIAN HORMONE; CASE-CONTROL STUDIES; FEMALE; HUMANS; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, FSH;

EID: 84859741876     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.633649     Document Type: Article

References (17)

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352: 1223-1236.
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
3. Homburg R. The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol 2003;1:109.
4. Advances in methods of fertility regulation: report of a WHO scientific group. World Health Organ Tech Rep Ser 1973;527:1-42.
5. Gurwitz D, Motulsky AG. 'Drug reactions, enzymes, and biochemical genetics': 50 years later. Pharmacogenomics 2007;8:1479-1484.
6. Mohiyiddeen L, Nardo LG. Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: future role in IVF. Hum Fertil (Camb) 2010;13:72-78.
7. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002;8:413-421.
8. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85:3365-3369.
9. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC, Simoni M. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril 2003;80:986-992.
10. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076-1084.
11. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957-5962.
12. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323-327.
13. Das M, Gillott DJ, Saridogan E, Djahanbakhch O. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Hum Reprod 2008;23:2122-2126.
14. Catteau-Jonard S, Jamin SP, Leclerc A, Gonzales J, Dewailly D, di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:4456-4461.
15. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999;51:97-99.
16. Overbeek A, Kuijper EA, Hendriks ML, Blankenstein MA, Ketel IJ, Twisk JW, Hompes PG, et al. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 2009;24:2007-2013.
17. Burgers JA, Fong SL, Louwers YV, Valkenburg O, de Jong FH, Fauser BC, Laven JS. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference? J Clin Endocrinol Metab 2010;95:E485-E489.